eversible RNA modification forms the epitranscriptomic code that regulates gene expression beyond the primary sequence 1, 2 . In eukaryotic cells, the most abundant internal RNA modification is N 6 -methyladenosine (m 6 A). m 6 A installation on RNA is mediated by a methyltransferase complex consisting of core subunits METTL3, METTL14, WTAP and other proteins such as KIAA1429 and RBM15 (refs. 3-5 ). This m 6 A 'writer' recognizes the consensus sequence RRACH (R, purine and H, non-guanine base), although not all the consensus sequences are methylated. The finding that FTO and ALKBH5 exhibit the demethylation activity toward m 6 A suggests the dynamic feature of m 6 A modification 6, 7 . The m 6 A mark is decoded by specific 'readers' to mediate a variety of downstream effects on RNA metabolism 8, 9 . A recent study further reported that m 6 A repels certain RNA-binding proteins 10 , forming an additional layer in controlling dynamic RNA-protein interaction. Despite the tremendous progress in the functional characterization of m 6 A modification, the regional effects of methylation on messenger RNA remain obscure. In particular, m 6 A takes on an asymmetric distribution along mRNA with the majority of methylation clustered near the stop codon 11, 12 . Recent m 6 A-seq studies also revealed m 6 A peaks in 5′ untranslated regions (UTR) and start codons when plotting the peak density along the transcriptome. However, current RNA biology tools do not distinguish the contributions of individual m 6 A modifications, imposing a substantial barrier to our understanding of the mechanism by which m 6 A markers influence cellular activities. Recent advances in CRISPR-based technologies have revolutionized biomedical research by enabling precision genome editing [13] [14] [15] . From targeted DNA cleavage/repair to direct base editing, genetic components can be engineered with high efficiency and specificity. Gene expression is also subjected to regulation by DNA methylation and histone modifications (the 'epigenome') 16, 17 . By fusing catalytically dead Cas9 (dCas9) to DNA or histone modifying enzymes, site-specific epigenome engineering becomes possible 18, 19 . With the availability of Cas proteins capable of targeting single-stranded RNA 20, 21 , programmable editing of epitranscriptome by coupling RNA-targeting Cas with RNA base-modifying enzymes would be attractive. However, such implementation is held back by several challenges. First, our knowledge about the RNA modification machinery remains rudimentary. Second, a direct sequencing method for quantitative profiling of site-specific RNA base modifications is still lacking. Third, the complex physiological effect of RNA modifications hinders functional interpretation of engineered epitranscriptome. In the case of m A is built on genetic perturbations of modifying enzymes that have pleiotropic effects on cellular physiology. It also inevitably affects global RNA methylation. To interrogate the regional effect of m 6 A, current methods often rely on point mutations that permanently remove the modification site from the transcript of interest. However, the altered nucleotide sequence may introduce unwanted properties and complicate data interpretation. It is thus highly desirable to develop a method that can manipulate individual m 6 A modifications at specific sites of individual transcripts without changing the primary sequence. We attempted to engineer the m 6 A machinery into a programmable RNA base modifier by taking advantage of RNA-guided dCas9 (refs. 20,21 ). m 6 A is installed on RNA molecules by a MTase complex comprising METTL3, METTL14 and WTAP via recognition of the consensus sequence RRACH (R, purine; H, non-guanine base) 8, 9 . Structural studies revealed that METTL3 pri- 
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eversible RNA modification forms the epitranscriptomic code that regulates gene expression beyond the primary sequence 1, 2 . In eukaryotic cells, the most abundant internal RNA modification is N 6 -methyladenosine (m 6 A). m 6 A installation on RNA is mediated by a methyltransferase complex consisting of core subunits METTL3, METTL14, WTAP and other proteins such as KIAA1429 and RBM15 (refs. [3] [4] [5] ). This m 6 A 'writer' recognizes the consensus sequence RRACH (R, purine and H, non-guanine base), although not all the consensus sequences are methylated. The finding that FTO and ALKBH5 exhibit the demethylation activity toward m 6 A suggests the dynamic feature of m 6 A modification 6, 7 . The m 6 A mark is decoded by specific 'readers' to mediate a variety of downstream effects on RNA metabolism 8, 9 . A recent study further reported that m 6 A repels certain RNA-binding proteins 10 , forming an additional layer in controlling dynamic RNA-protein interaction. Despite the tremendous progress in the functional characterization of m 6 A modification, the regional effects of methylation on messenger RNA remain obscure. In particular, m 6 A takes on an asymmetric distribution along mRNA with the majority of methylation clustered near the stop codon 11, 12 . Recent m 6 A-seq studies also revealed m 6 A peaks in 5′ untranslated regions (UTR) and start codons when plotting the peak density along the transcriptome. However, current RNA biology tools do not distinguish the contributions of individual m 6 A modifications, imposing a substantial barrier to our understanding of the mechanism by which m 6 A markers influence cellular activities. Recent advances in CRISPR-based technologies have revolutionized biomedical research by enabling precision genome editing [13] [14] [15] . From targeted DNA cleavage/repair to direct base editing, genetic components can be engineered with high efficiency and specificity. Gene expression is also subjected to regulation by DNA methylation and histone modifications (the 'epigenome') 16, 17 . By fusing catalytically dead Cas9 (dCas9) to DNA or histone modifying enzymes, site-specific epigenome engineering becomes possible 18, 19 . With the availability of Cas proteins capable of targeting single-stranded RNA 20, 21 , programmable editing of epitranscriptome by coupling RNA-targeting Cas with RNA base-modifying enzymes would be attractive. However, such implementation is held back by several challenges. First, our knowledge about the RNA modification machinery remains rudimentary. Second, a direct sequencing method for quantitative profiling of site-specific RNA base modifications is still lacking. Third, the complex physiological effect of RNA modifications hinders functional interpretation of engineered epitranscriptome. In the case of m 6 A modification, it is unclear whether particular outcomes require a single RNA methylation event or an ensemble of m 6 A modifications that function as a synergistic unit.
Here we report the development of 'm 6 A editing' , a powerful approach that enables m 6 A installation and erasure from cellular RNAs without changing the primary sequence. We created engineered m 6 A 'writers' by fusing CRISPR-Cas9 and a single-chain m 6 A methyltransferase. We further engineered m 6 A 'erasers' by fusing CRISPR-Cas9 with full-length ALKBH5 or FTO to achieve sitespecific demethylation of RNAs. The resultant m 6 A editors can be programmed with a guide RNA, allowing functional comparison of single site methylation in different mRNA regions.
Results
Designing programmable m 6 A writers. Much of our knowledge of m 6 A is built on genetic perturbations of modifying enzymes that have pleiotropic effects on cellular physiology. It also inevitably affects global RNA methylation. To interrogate the regional effect of m 6 A, current methods often rely on point mutations that permanently remove the modification site from the transcript of interest. However, the altered nucleotide sequence may introduce unwanted properties and complicate data interpretation. It is thus highly desirable to develop a method that can manipulate individual m 6 A modifications at specific sites of individual transcripts without changing the primary sequence. We attempted to engineer the m 6 A machinery into a programmable RNA base modifier by taking advantage of RNA-guided dCas9 (refs. 20, 21 ). m 6 A is installed on RNA molecules by a MTase complex comprising METTL3, METTL14 and WTAP via recognition of the consensus sequence RRACH (R, purine; H, non-guanine base) 8, 9 . Structural studies revealed that METTL3 priProgrammable RNA N
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-methyladenosine editing by CRISPR-Cas9 conjugates marily functions as the catalytic core, while METTL14 serves as an RNA-binding platform 22, 23 . Since the METTL3-METTL14 heterodimer possesses strong catalytic activity, we constructed a single-chain m 6 A MTase by linking two MTase domains derived from human METTL3 and METTL14, respectively (Fig. 1a) . We expressed and purified two fusion proteins with different orientations of MTase domains. In vitro methyltransferase assay showed that M3M14 exhibited more than three-fold higher catalytic activity than M14M3 ( Supplementary Fig. 1a) . Consistent with the previous finding that AdoMet binds to the DPPW motif of METTL3 (refs. 22, 23 ), introducing D395A mutation abolished the catalytic activity of both recombinant proteins ( Supplementary Fig. 1a) .
We next fused M3M14 to the amino terminus of dCas9 using the same linker designed for the DNA base editor ( Supplementary  Fig. 1b) 
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. Unlike the endogenous METTL3 or METTL14, which are primarily localized in the nucleus, both M3M14-dCas9 and M3 D395A M14-dCas9 fusion proteins showed predominant cytosolic localization in transfected human embryonic kidney (HEK)293T and mouse embryonic fibroblast (MEF) cells ( Supplementary Fig.  1c,d ). Although physiological m 6 A modification occurs on nascent RNAs in a co-transcriptional manner 25 , the cytosolic presence of engineered m 6 A 'writers' offers an attractive approach to targeting mature RNAs for de novo methylation. Similar to DNA-targeting dCas9, RNA-targeting dCas9 requires sequence-specific guide RNA (sgRNA) and the protospacer adjacent motif (PAM) supplied by an antisense oligonucleotide (PAMer) (Fig. 1a) . Consistent with the previous report 20 , we found that PAMer is essential for efficient binding of M3M14-dCas9 to the target RNA ( Supplementary  Fig. 2a ). With two regional base pairing conferred by sgRNA and PAMer, possible off-targeting of dCas9 can be minimized, thereby increasing the specificity of RNA targeting.
Programmable 5′ UTR m 6
A modification. To assess whether M3M14-dCas9 is capable of inducing site-specific m 6 A modification, we first designed sgRNAs targeting the 5′ UTR of Hsp70 mRNA. Since the level of endogenous Hspa1a is undetectable in MEF cells under the normal growth condition, we introduced a firefly luciferase (Fluc) reporter bearing the 5′ UTR of Hspa1a (Fig. 1b) . In transfected MEF cells, the exogenous 5′ UTR exhibited basal m A mark because it is highly sensitive to METTL3 knockdown ( Supplementary Fig. 2b ). To test whether M3M14-dCas9 can further boost the m 6 A signal at this position, we designed a panel of four sgRNAs with their 5′ ends located at varied distances to A103 (Fig. 1b) . Overexpression of M3M14-dCas9 alone had negligible effect on total RNA methylation ( Supplementary Fig. 2c ). A consensus motif on target RNA. PAMer supplies the PAM sequence NGG that does not need to be present on target RNA. b, Measurement of m 6 A levels on Hspa1a 5′ UTR-Luc in transfected HeLa cells. λ2 sgRNA was used as the non-targeting control. Primers were designed to span the targeting m 6 A site A103 in Hspa1a 5′ UTR or A1280 of Fluc mRNA as control for off-targeting. Error bars, mean ± s.e.m.; unpaired Student's t-test, *P < 0.05, **P < 0.01; n = 4 independent experiments. c, Site-specific detection of m 6 A on Hspa1a 5′ UTR-Luc in transfected HeLa cells using fluorescein-dUTP-incorporated primer-extension approach. Both specific (A103) and non-specific (A1280) sites were detected from the same sample. Red boxes highlight decreased probe +1 signals as a result of increased methylation by M3M14-dCas9 but not the inactive mutant. This experiment was repeated twice with similar results. Uncropped scans are shown in Supplementary Fig. 11 . d, Measurement of m 6 A levels on endogenous Hsph1 5′ UTR in MEF cells transfected with engineered m 6 A 'writers'. λ2 sgRNA was used as the non-targeting control. Error bars, mean ± s.e.m.; unpaired Student's t-test, *P < 0.05; n = 4 independent experiments.
However, co-transfection of sgRNA and PAMer resulted in sitespecific m 6 A modification at A103 of Hspa1a-Fluc with varied efficiencies (Fig. 1b) . We observed a >50% increase of m 6 A signals for sgRNA(b) and sgRNA(c), suggesting an effective window of ~10 nucleotides for targeted methylation. This is consistent with the flexible nature of the XTEN linker between M3M14 and dCas9. The increased methylation was due to the catalytic activity of the engineered m 6 A 'writer' because little methylation was observed on expression of M3 D395A M14-dCas9. The induced m 6 A modification was site-specific because a putative m 6 A site at the coding region of Fluc (A1280) showed comparable methylation signals regardless of the sgRNA presented (Fig. 1b, right panel) . m 6 A-RIP coupled with RT-qPCR, albeit quantitative, does not offer single nucleotide resolution. A sequencing-based approach, miCLIP, provides single nucleotide m 6 A mapping but lacks quantitative features 26 . To circumvent these limitations, we devised site-specific m 6 A quantification by coupling m 6 A antibody crosslinking with probe elongation 27 . We validated this approach by using synthetic RNAs containing A or m 6 A at specific positions ( Supplementary  Fig. 2d ). When Hspa1a-Fluc was examined from transfected cells, we observed an evident reduction of the 'probe+1' signal at A103 in the presence of sgRNA(b) or sgRNA(c) (Fig. 1c) . Since a decreased 'probe+1' signal is an indication of increased methylation events, this result is in agreement with m Supplementary Fig. 3b ). These results collectively confirmed that M3M14-dCas9 is able to achieve sgRNA-guided site-specific m 6 A modification. We noticed that, for Hsp70 5′ UTR, the targeted m 6 A modification efficiency is relatively low. This could be due to the high basal level of methylation at this position that limits the extent of further increase. We next chose the 5′ UTR from Hsp105 that has relatively low methylation levels in MEFs as evidenced by m 6 A-seq ( Supplementary Fig. 4a ). Further, knocking down the methyltransferase METTL3 had limited effect on the level of methylation. By contrast, silencing the demethylase FTO significantly increased the steady-state m 6 A levels in the 5′ UTR of Hsp105 ( Supplementary  Fig. 4b ). Notably, the 5′ UTR of Hsp105 contains a cluster of putative m 6 A sites, which could be targeted by the same sgRNA. We constructed a Fluc reporter bearing the mouse Hsp105 5′ UTR and designed two sgRNAs targeting the m 6 A cluster. In transfected HeLa cells, two sgRNAs each induced ~two-fold increase of 5′ UTR methylation catalyzed by M3M14-dCas9 but not the inactive M3 D395A M14-dCas9 ( Supplementary Fig. 4c ). Once again, the nontargeted m 6 A site (A1280) of the same transcript showed little difference of methylation, confirming the specificity of programmable m 6 A modification. This encouraging result prompted us to examine whether the engineered m 6 A 'writer' is able to target the endogenous transcript in MEF cells. This was indeed the case as the same sgRNAs significantly increased the 5′ UTR methylation of Hsph1 in transfected MEFs (Fig. 1d) .
Effects of targeted 5′ UTR m 6
A modification. The 5′ UTR is crucial for ribosome scanning and it is unclear whether the binding of CRISPR-Cas9 system in the 5′ UTR would interfere with the normal translation process (Fig. 2a) . A previous study reported that CRISPR-Cas9 targeting 5′ UTR or the coding region inhibited mRNA translation by acting as a roadblock 29 . Using the Fluc reporter assay, we found that the presence of sgRNA or PAMer alone does not seem to block the ribosome scanning process despite the sequence complementarity to the 5′ UTR of Hsp105 (Supplementary Fig. 5a ). Additionally, co-transfection with M3M14-dCas9 had negligible effect on Fluc levels, at least under the normal growth condition (Supplementary Fig. 5b ). We previously reported that 5′ UTR methylation in the form of m 6 A enables cap-independent translation under stress conditions 30, 31 . We next subjected the transfected cells to heat shock stress at 42 °C for 1 h, which denatured preexisting Fluc. During stress recovery, we observed an increased Fluc levels in the presence of M3M14-dCas9 when compared to the inactive mutant (Fig. 2b) . The steady-state levels of Fluc mRNA were comparable, suggesting a translational effect. The same phenomenon holds true for Hsp70 5′ UTR (Fig. 2b) . These results support the notion that 5′ UTR m 6 A promotes non-canonical translation when the cap-dependent mechanism is repressed.
Accumulating evidence suggests the role of m 6 A modification in promoting mRNA degradation 32 . However, it is unclear whether the m 6 A mark installed at different regions exhibits distinct effects. Programmable m 6 A 'writing' permits functional dissection of sitespecific effects of methylation without introducing point mutations. We first assessed the effect of 5′ UTR methylation on mRNA stability by taking advantage of Fluc mRNAs bearing Hsp105 5′ UTR. To evaluate the turnover rate of Fluc mRNA, we treated transfected cells with the transcription inhibitor actinomycin D for various times followed by RT-qPCR. Despite the two-fold increase of m 6 A in 5′ UTR catalyzed by M3M14-dCas9 ( Supplementary Fig. 4c ), we observed little difference of mRNA turnover ( Supplementary  Fig. 5c ). Similarly, Hsp70 5′ UTR had no effects on the stability of Fluc mRNA regardless of the methylation status ( Supplementary  Fig. 5d ). The negligible effect of 5′ UTR methylation on mRNA turnover could be due to the eviction of potential m Fig. 6b ). To examine whether a single site m 6 A modification in the 3′ UTR contributes to the degradation of Actb, we designed two sgRNAs and corresponding PAMers targeting A1216 (Fig. 2c) . In transfected HeLa cells, only sgRNA(a) increased the methylation at A1216 (~three-fold) as quantified by m 6 A-RIP (Fig. 2c) . As an independent validation, we conducted site-specific m 6 A quantification. Indeed, only sgRNA(a) reduced the 'probe+1' signal at A1216 of β-actin mRNA, corresponding to the increased methylation (Fig. 2d) . Notably, the same sample showed little difference of methylation at A2577 of Malat1, a non-coding RNA as a non-targeting internal control (Fig. 2d) . To substantiate the targeting specificity of m 6 A modification by the engineered m 6 A writer, we applied SELECT to the same samples and observed significant reduction of ligated products by sgRNA(a), an indication of increased m 6 A levels ( Supplementary Fig. 6c ). Although ectopic expression of M3M14-dCas9 does not seem to alter global RNA methylation ( Supplementary Fig. 2c ), it is unclear whether the presence of particular sgRNAs leads to off-targeting of m 6 A methylation. To assess the off-targeting possibility of Actb-specific sgRNA(a) across the transcriptome, we conducted optimized m 6 A-seq. With improved resolution ( Supplementary  Fig. 7a,b) , we compared the entire m 6 A methylome in cells expressing active or inactive m 6 A writer, in the presence of targeted sgRNA or λ2 sgRNA control. The overall m 6 A landscapes across the transcriptome are comparable in these cells (Supplementary Fig. 7c ). Pair-wise comparison of individual m 6 A sites showed limited variation ( Supplementary Fig. 7d ). The targeted site of Actb showed an evident increase of m 6 A density in cells expressing M3M14-dCas9 when compared to the inactive mutant ( Supplementary Fig. 7e ). Although different sgRNAs could have different outcomes, the possible off-target of sgRNA-guided m 6 A writers is either negligible or beyond the detection threshold.
Having achieved site-specific 3′ UTR m 6 A modification of β-actin mRNA by sgRNA(a), we next examined the stability of endogenous Actb in these cells. The half-life of Actb was significantly reduced in the presence of MTase-dCas9, but not MTase D395A -dCas9 (Fig. 2e) . Notably, the non-targeted transcript Gapdh maintained its stability in the same samples ( Supplementary Fig. 7f ). The correlation between sgRNA(a)-guided m 6 A installation and increased mRNA turnover suggests that a single m 6 A modification at 3′ UTR influences the mRNA stability.
Designing programmable m 6 A erasers. To fully interrogate the regional effect of m 6 A modification, it is highly desirable to achieve targeted erasure of m 6 A from mRNA using engineered demethylases. Two members of the α-ketoglutarate-dependent dioxygenases protein family, FTO and ALKBH5, have been shown to act as m 6 A demethylases 6, 7 . Unlike m 6 A 'writers' that require consensus motif for targeting, the substrate specificity of ALKBH5 and FTO seems to rely on conformational markers signified by m 6 A
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. In addition to internal m 6 A, FTO can also demethylase m 6 Am adjacent to the 5′ end cap 35, 36 . Since the non-AlkB domains are crucial in the functionality of both demethylases, we fused the full-length ALKBH5 or FTO to the amino terminus of dCas9 (Fig. 3a) . To generate inactive controls, we introduced H204A mutation to ALKBH5 and (H231A, D233A) double mutations to FTO ( Supplementary Fig. 8a,d ). These fusion proteins primarily localized in the nucleus of transfected cells as expected ( Supplementary Fig. 8b,e) . Notably, overexpression of these engineered 'erasers' alone did not alter global m 6 A levels in transfected cells ( Supplementary Fig. 8c,f) . To assess the off-targeting effect, we conducted optimized m 6 A-seq and compared the entire m 6 A methylome in cells expressing active or inactive FTOdCas9, in the presence of targeted sgRNA or λ2 sgRNA control. The overall m 6 A landscapes across the transcriptome are comparable in these cells (Supplementary Fig. 9a ). Pair-wise comparison of individual m 6 A sites showed that the global variation in the presence of targeted sgRNA is no greater than the control (Supplementary Fig. 9b) .
To evaluate the sgRNA-guided demethylation activity of ALKBH5-dCas9 and FTO-dCas9, we chose to target Malat1 because this abundant long non-coding RNA exhibits a high degree of methylation at A2577 (80% in HeLa cells) ( Supplementary Fig. 10a ) 33 . We designed two sgRNAs and corresponding PAMers targeting A2577 of Malat1. Only sgRNA(a) was able to reduce its methylation when co-expressed with either ALKBH5-dCas9 or FTO-dCas9 (Fig. 3b) . This was due to the demethylase activity of engineered m 6 A erasers because inactive mutants of ALKBH5 did not alter the m 6 A signal at A2577 of Malat1 (Fig. 3c) . The m 6 A levels at A1216 of Actb were comparable in the presence of sgRNA(a) targeting Malat1. The high specificity of ALKBH5-dCas9 was further confirmed using A 'writers' on ribosome scanning and subsequent translation. b, Translational effects of targeted 5′ UTR m 6 A modification in transfected HeLa cells before and after heat shock (42 °C for 1 h). Fluc activities were monitored during heat shock (HS) stress recovery. Fluc mRNA levels were also measured in parallel. Error bars, mean ± s.e.m.; unpaired Student's t-test, *P < 0.05; n = 3 independent experiments. c, Measurement of m 6 A levels on endogenous Actb 3′ UTR in HeLa cells transfected with engineered m 6 A 'writers'. λ2 sgRNA was used as the non-targeting control. Primers were designed to span the targeting m 6 A site at A1216 of Actb 3′ UTR. Error bars, mean ± s.e.m.; unpaired Student's t-test, **P < 0.01; n = 4 independent experiments. d, Site-specific detection of m 6 A on endogenous Actb in transfected HeLa cells using fluorescein-dUTP-incorporated primer-extension approach. In addition to the specific site (A1216) of Actb, the non-specific site (A2577 of Malat1) from the same sample was used as negative control. Red boxes highlight decreased probe+1 signals as a result of increased methylation by M3M14-dCas9 but not the inactive mutant. This experiment was repeated three times with similar results. Uncropped scans are shown in Supplementary Fig. 11 . e, Measurement of Actb decay in HeLa cells transfected with engineered m 6 A 'writers'. Then, 36 h after transfection, cells were treated with actinomycin D for various times before sample collection for RT-qPCR. Error bars, mean ± s.e.m.; unpaired Student's t-test, *P < 0.05; n = 3 independent experiments. site-specific m 6 A quantification (Fig. 3d) . The same finding holds true for FTO-dCas9 (Fig. 3e,f) , validating the specificity of programmable m 6 A erasers. A editing of Malat1 acts as a structural switch. Only sgRNA(a) enables site-specific Malat1 demethylation. To substantiate this finding further, we employed the SELECT analysis and confirmed the differential effect between sgRNA(a) and sgRNA(b) (Fig. 4a,b) . m 6 A at A2577 has been reported to act as a structural switch for Malat1 by destabilizing the stem structure 37 . As a result, the exposed U-tract allows subsequent binding of heterogeneous nuclear ribonucleoprotein C (HNRNPC) (Fig. 4c and Supplementary Fig. 10b ). Since sgRNA(b) is located upstream of the U-tract, it is possible that the presence of HNRNPC prevents the access of engineered m 6 A 'erasers' to the target site. As an independent means to evaluate the methylation status of Malat1, we conducted HNRNPC immunoprecipitation coupled with RT-qPCR of Malat1. Once again, only sgRNA(a) significantly reduced the Malat1-associated HNRNPC (Fig. 4c) , confirming the functional consequence of m 6 A erasure from A2577 of Malat1. This result indicates that m 6 A editing has the potential to control interactions of RNA-binding proteins by remodeling RNA structures. The comparable catalytic activities between ALKBH5-dCas9 and FTO-dCas9 also indicate that FTO is capable of targeting internal m 6 A.
Discussion
A challenge in the post-genomic era has been to elucidate the complex layers of epigenetic control of gene expression. Over the past 30 years, much research has been conducted on how DNA methylation and histones modifications (the 'epigenome') regulate gene expression 16, 17 . More recently, RNA modifications have been discovered that decorate all RNA species across many living organisms. Dynamic and reversible RNA modifications constitute the 'epitranscriptome' , a tunable layer influencing nearly all aspects of RNA metabolism and functionality 1, 2 . Much of our current knowledge about RNA post-transcriptional modifications is limited to studies that rely on genetic perturbations that affect global RNA methylation as a whole. Although these results are informative for implicating the significance of RNA markers in cellular regulation, they are too limited for detailed mechanistic dissection. Additionally, the asymmetric m 6 A deposition suggests that regional methylation may have distinct functional consequences. To interrogate the sitespecific effect of m 6 A, point mutation is a common methodology to permanently remove the modification site. However, we lack an approach to m 6 A installation in a site-specific manner. By coupling CRISPR-Cas9 technology, the m 6 A editors described here offer researchers a versatile toolbox to unlock the secrets of epitranscriptome. It is now possible to achieve site-specific m 6 A installation or erasure, which is key to understanding the regional effects of mRNA methylation. We confirmed that a single site 5′ UTR methylation enables non-canonical mRNA translation. By contrast, manipulating 3′ UTR methylation influences mRNA turnover but not in an exclusive manner. One important application of m 6 A editing is to alter RNA secondary structures without changing the primary sequence. By site-specific m 6 A editing, certain m 6 Adependent RNA structural switches can now be remodeled, offering A using the same samples as c. Red boxes highlight increased probe +1 signals as a result of reduced methylation by ALKBH5-dCas9 but not the inactive mutant. This experiment was repeated twice with similar results. Uncropped scans are shown in Supplementary Fig. 11 . e, Measurement of m 6 A levels on A2577 of Malat1 and A1216 of Actb in HeLa cells transfected with active or inactive FTO-dCas9 in the presence of sgRNA(a). Error bars, mean ± s.e.m.; unpaired Student's t-test, ***P < 0.001; n = 4 independent experiments. f, Sitespecific detection of m 6 A using the same samples as e. Red boxes highlight increased probe+1 signals as a result of reduced methylation by FTO-dCas9 but not the inactive mutant. This experiment was repeated twice with similar results. Uncropped scans are shown in Supplementary Fig. 11 .
a powerful approach to fine-tuning specific RNA-protein interactions. With the versatility of CRISPR-Cas enzymes on the rise 15 , it is conceivable to construct m 6 A editors with smaller size, higher specificity and more adjustable features such as the one inducible by small molecules. Given the broad range of chemical modifications in cellular RNAs, our approach also serves as a prototype for developing toolkits capable of editing diverse base or sugar modifications of RNA molecules.
online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of code and data availability and associated accession codes are available at https://doi.org/10.1038/ s41589-019-0327-1. Plasmid constructions and PAMmer synthesis. Full-length coding sequences (CDSs) of human METTL3 and METL14 were cloned into pcDNA3.1 (Invitrogen) to generate pcDNA-Mettl3 and pcDNA-Mettl14 plasmids. DNA sequences encoding methytransferase domain of METTL3 (residue 369-580) and METTL14 (residue 116-402) were amplified from pcDNA-Mettl3 and pcDNA-Mettl14, respectively, and subcloned into pCMV-BE2 vector backbone (Addgene no. 73020) using Gibson assembly (NEB E2611S). The resulting plasmid was used as a template to produce the methytransferase inactive mutant plasmid (M3 D395A M14-dCas9) using Q5 Site-Directed Mutagenesis Kit (NEB E0554S). Full-length coding sequences of human ALKBH5 and FTO were directly cloned into BE2 vector using Not I and Sma I to generate ALKBH5-dCas9 and FTO-dCas9. The UGI sequences were removed from both vectors. The resulting plasmids were used as templates to generate the demethylase inactive mutant plasmids (ALKBH5H204A-dCas9 and FTOH231A/D233A-dCas9) using Q5 Site-Directed Mutagenesis Kit (NEB E0554S). To purify M3M14 fusion protein from bacteria, M3M14 DNA sequence was amplified from M3M14-dCas9 and subcloned into pGEX-6P-1 vector using Xho I and Not I. sgRNAs were designed based on the target m 6 A site for individual RNA and cloned into Cas9 sgRNA vector (Addgene no. 68463). PAMmers were designed based on the principles as previously described 20 , 21 . The HPLC-purified PAMer sequences consisting of mixed DNA and 2'OMe RNA bases were commercially synthesized by Integrated DNA Technologies. DNA sequences of all primers, sgRNAs and PAMers used in this study are listed in the Supplementary Table 1.
In vitro methylation assay. The RNA probe (5′-CGAUCCUCGGCCAGGACC AGCCUUCCCCAG-3′) derived from Hsp70 5′ UTR was commercially synthesized in vitro (Thermo Fisher Scientific). Fusion proteins of M3M14, M14M3 and their catalytically inactive forms were purified from bacteria. The in vitro methylation assay was performed in a 50 µl reaction mixture containing 400 nM RNA probe, 20 mM Tris (pH 7.5), 50 µM ZnCl 2 , 1 mM DTT, 0.01% Triton X, 0.2 U µl -1 RNaseOUT, 1% glycerol, 0.5 μCi (methyl-3 H)AdoMet (PerkinElmer) and 100 nM purified protein. The reaction was incubated at 30 °C for 1 h and then stopped by adding Trizol reagent (Invitrogen). RNA after reaction was precipitated and purified using sodium acetate at −20 °C for at least 2 h. The precipitated RNA was subjected to radioactivity measurement using scintillation counting (Beckman). Levels of A immunoprecipitation. Total RNA was isolated using Trizol reagent. Subsequently, the RNA was fragmentized in freshly prepared RNA fragmentation buffer (10 mM Tris-HCl pH 7.0, 10 mM ZnCl 2 ). Then, 180 μg fragmented RNA was incubated with 6 μg anti-m 6 A antibody in 1× m 6 A IP buffer (10 mM Tris-HCl pH 7.4, 150 mM NaCl and 0.1% Igepal CA-630) supplemented with 6 µl RNaseOUT (40 U µl Immunofluorescence staining. Cells were seeded on glass coverslips at about 70% confluence followed by fixation in 4% paraformaldehyde for 10 min at 4 °C. Subsequently, the fixed cells were treated with 0.2% Triton X-100 at room temperature for 5 min for permeabilization followed by incubation with 1% bovine serum albumin (BSA) for 1 h. After blocking, cells were incubated with anti-Cas9 antibody (Millipore MAC133) overnight at 4 °C and then with Alexa Fluor 546 donkey anti-mouse secondary antibody for 1 h at room temperature. DAPI (1:1,000 dilution)-stained compartments serve as markers of the nuclei. The glass slips were stuck on slides using nail polish and prepared for imaging using a Zeiss LSM710 confocal microscope.
Western blot. Cells were washed twice in PBS and harvested by adding SDS sample buffer (50 mM Tris pH 6.8, 100 mM dithiothreitol, 2% SDS, 0.1% bromophenol blue, 10% glycerol) followed by heating for 10 min at 95 °C. The boiled samples were loaded on SDS-PAGE gels and separated by electrophoresis for about 2 h. The gels were removed from plates and transferred onto Immobilon-P membranes (Millipore) via XCell II Blot Module (Invitrogen). The polyvinylidene difluoride membranes were blocked for 1 h in blocking buffer (1× TBS, 5% non-fat milk and 0.1% Tween-20). Subsequently, the membranes were incubated with primary antibodies overnight at 4 °C followed by blotting with secondary antibodies at room temperature for 1 h. The blotting signal was visualized after reaction with enhanced chemiluminescence (ECL Plus, GE Healthcare). m 6 A site-specific detection. Total RNA was isolated from cells 36-48 h after transfection with components for targeted methylation of Hsp70 5′ UTR and β-actin or demethylation of Malat1. In detail, 20 μg total RNA was diluted in 450 μl immunoprecipitation buffer (50 mM Tris, pH 7.4, 100 mM NaCl, 0.05% NP40) and incubated with 1 μg m 6 A antibody at 4 °C for 2 h, rotating head over tail. The antibody-RNA mixture was then crosslinked twice under the conditions with ultraviolet light at 254 nm 0.15 J cm -2 in a Stratalinker (Agilent), followed by precipitation of RNA in 1 ml ethanol and 45 μl sodium acetate. Reverse transcription was performed in a total volume of 7 μl reaction containing m 6 Acrosslinked RNA, Tth buffer (Promega) and 50 pmole primer. The sequences of the primers targeting m 6 A sites were listed as follows: Primer targeting Hspa1a 5′ UTR, 5′-AGGGATGCTCTGGGGAAGGCTGG-3′; Primer targeting Fluc coding region: 5′-GCGGTCAACGATGAAGAAGTGTTCGTCTTCG-3. Primer targeting Actb, 5′-CAAGAAAGGGTGTAACGCAACTAAGTCATAG-3′; Primer targeting Malat1, 5′-CAATTAATGCTAGTCCTCAGGATTTAAAAAATAATCTTAACTCAAAG-3′. Subsequently, the reaction mixture was heated at 95 °C for 10 min and gradually cooled to room temperature. Following annealing, 5 U of Tth enzyme and 1 mM MnCl 2 were added into the mixture and heated at 70 °C for 3 min. Primer extension was initiated by addition of 1 μM Fluorescein-12-dUTP and reacted for 15 min at 70 °C. The reverse transcription products were resolved on a 15% Novex TBE-urea gels (Thermo Fisher Scientific) and 6-carboxyfluorescein signal was detected by Typhoon 9400 variable mode imager. Table 2 .
RT-qPCR. Total RNA was isolated from PBS-washed cells using Trizol reagent. Isolated RNAs were used as templates for reverse transcription based on the manual for High Capacity complementary DNA Reverse Transcription Kit (Invitrogen). Synthesized cDNAs were mixed with Power SYBR Green PCR Master Mix (Applied Biosystems) for qPCR in 384-well plates. The reactions were performed in a LightCycler 480 Real-Time PCR System (Roche Applied Science). Primers used in the qPCR assay are listed in the Supplementary Table 3. m6A dot blot. RNA was isolated from transfected cells. Equal amounts of RNA were dropped on a nylon membrane (Thermo Fisher Scientific) followed by crosslinking under conditions of ultraviolet light at 254 nm, 0.12 J cm -2 . The membrane was blocked in PBS with Tween (PBST) (5% non-fat milk and 0.1% Tween-20) for 1 h and subsequently incubated with anti-m 6 A antibody (1:1,000 dilution) overnight at 4 °C. After washing three times in PBST buffer, the membrane was blotted with secondary antibody (anti-rabbit, 1:5,000) at room temperature for 1 h. The dot blotting signal was visualized after reaction with enhanced chemiluminescence (ECL Plus, GE Healthcare).
RNA immunoprecipitation.
For detection of M3M14-dCas9-sgRNA complex binding to target RNA sequence, HeLa cells were co-transfected with Hsph1-Fluc, M3M14-dCas9, control or target sgRNA and increasing dose of PAMer. For detection of HNRNPC binding to MALAT1, cells were transfected with target sgRNA, PAMer, control dCas9, ALKBH5-dCas9 or FTO-dCas9. Then, 36 h after transfection, cells were incubated with the growth media containing 1% formaldehyde for 10 min at room temperature, followed by termination
